The tweet was deleted by the author.
But we saved everything 🙂.
Howard Lutnick is raising concerns over Harvard University's compliance with the Bayh-Dole Act.
The Bayh-Dole Act, which allows universities to retain patents on inventions developed through federally funded research, aims to encourage commercialization of innovations. Lutnick believes that ''taxpayers deserve the benefit of the bargain'' and has stated that if Harvard will not honor the act, then he will find someone who will. The specifics of Lutnick's statement or the potential actions he might undertake are not detailed further at this time.
Lutnick’s latest statements on regulatory compliance reinforce his ongoing focus on the intersection of government policy and corporate responsibility. His recent perspectives have accompanied developments such as AstraZeneca’s decision to allocate $50 billion toward U.S. manufacturing expansion, a move detailed in his previous coverage of substantial investment in domestic industry. Similarly, his support for Trump tariff policies to ensure fair competition underscores a consistent advocacy for equitable frameworks guiding both innovation and trade.